BDNF gene variants and brain morphology in schizophrenia.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMID 16741916)

Published in Am J Med Genet B Neuropsychiatr Genet on July 05, 2006

Authors

Ingrid Agartz1, Göran C Sedvall, Lars Terenius, Bettina Kulle, Arnoldo Frigessi, Håkan Hall, Erik G Jönsson

Author Affiliations

1: Department of Clinical Neuroscience, Human Brain Informatics, Karolinska Institutet and Hospital, Stockholm, Sweden. Ingrid.Agartz@medisin.uio.no

Articles citing this

Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia. Biol Psychiatry (2011) 1.56

Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. Am J Psychiatry (2007) 1.33

The changing impact of genes and environment on brain development during childhood and adolescence: initial findings from a neuroimaging study of pediatric twins. Dev Psychopathol (2008) 1.20

Abnormal brain connectivity in first-episode psychosis: a diffusion MRI tractography study of the corpus callosum. Neuroimage (2006) 1.20

Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct "extended endophenotypes"? Schizophr Bull (2008) 1.12

Cognitive heterogeneity in schizophrenia. Curr Opin Psychiatry (2007) 0.98

Cerebellum volume in high-risk offspring from multiplex alcohol dependence families: association with allelic variation in GABRA2 and BDNF. Psychiatry Res (2011) 0.97

Neuropeptides in depression: role of VGF. Behav Brain Res (2008) 0.97

A functional polymorphism of the brain derived neurotrophic factor gene and cortical anatomy in autism spectrum disorder. J Neurodev Disord (2009) 0.96

Genetic patterns of correlation among subcortical volumes in humans: results from a magnetic resonance imaging twin study. Hum Brain Mapp (2011) 0.94

Neural plasticity, human genetics, and risk for alcohol dependence. Int Rev Neurobiol (2010) 0.94

Decrease in temporal gyrus gray matter volume in first-episode, early onset schizophrenia: an MRI study. PLoS One (2012) 0.93

What happens in the brain of schizophrenia patients?: an investigation from the viewpoint of neuropathology. Nagoya J Med Sci (2013) 0.92

Impact of the brain-derived neurotrophic factor Val66Met polymorphism on levels of hippocampal N-acetyl-aspartate assessed by magnetic resonance spectroscopic imaging at 3 Tesla. Biol Psychiatry (2008) 0.90

Neurocognitive-genetic and neuroimaging-genetic research paradigms in schizophrenia and bipolar disorder. J Neural Transm (Vienna) (2011) 0.86

Vascular endothelial growth factor and brain-derived neurotrophic factor in quetiapine treated first-episode psychosis. Schizophr Res Treatment (2014) 0.79

Paradoxical visuomotor adaptation to reversed visual input is predicted by BDNF Val66Met polymorphism. J Vis (2014) 0.77

Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism and Risk of Schizophrenia: A Meta-analysis of Case-Control Studies. Cell Mol Neurobiol (2015) 0.75

Articles by these authors

Common variants conferring risk of schizophrenia. Nature (2009) 10.37

A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature (2012) 8.10

Evaluation of diagnostic procedures in Swedish patients with schizophrenia and related psychoses. Nord J Psychiatry (2005) 3.22

GSEA-SNP: applying gene set enrichment analysis to SNP data from genome-wide association studies. Bioinformatics (2008) 2.52

Equivalence test in quantitative reverse transcription polymerase chain reaction: confirmation of reference genes suitable for normalization. Anal Biochem (2004) 2.28

Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors. Acta Radiol (2010) 2.26

Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet (2011) 2.21

The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90

NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity. Circulation (2005) 1.87

Brain expressed microRNAs implicated in schizophrenia etiology. PLoS One (2007) 1.85

Phase II trial of carcinoembryonic antigen radioimmunotherapy with 131I-labetuzumab after salvage resection of colorectal metastases in the liver: five-year safety and efficacy results. J Clin Oncol (2005) 1.83

Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain. Hum Brain Mapp (2004) 1.76

The Genomic HyperBrowser: inferential genomics at the sequence level. Genome Biol (2010) 1.74

TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice. J Clin Invest (2007) 1.63

Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy. J Clin Oncol (2006) 1.57

Climatically driven synchrony of gerbil populations allows large-scale plague outbreaks. Proc Biol Sci (2007) 1.51

Association analysis of schizophrenia on 18 genes involved in neuronal migration: MDGA1 as a new susceptibility gene. Am J Med Genet B Neuropsychiatr Genet (2008) 1.50

Genome-wide single-nucleotide polymorphism arrays demonstrate high fidelity of multiple displacement-based whole-genome amplification. Electrophoresis (2005) 1.45

Regional thinning of the cerebral cortex in schizophrenia: effects of diagnosis, age and antipsychotic medication. Schizophr Res (2007) 1.39

Eight genes are highly associated with BMD variation in postmenopausal Caucasian women. Bone (2009) 1.30

The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. Am J Hum Genet (2003) 1.26

The Genomic HyperBrowser: an analysis web server for genome-scale data. Nucleic Acids Res (2013) 1.20

Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder. J Psychiatry Neurosci (2010) 1.19

Neuroadaptations in human chronic alcoholics: dysregulation of the NF-kappaB system. PLoS One (2007) 1.19

The influence of missing value imputation on detection of differentially expressed genes from microarray data. Bioinformatics (2005) 1.17

NK cells: elusive players in autoimmunity. Trends Immunol (2005) 1.17

DAP12 signaling regulates plasmacytoid dendritic cell homeostasis and down-modulates their function during viral infection. J Immunol (2006) 1.11

[(11)C]PIB-amyloid binding and levels of Abeta40 and Abeta42 in postmortem brain tissue from Alzheimer patients. Neurochem Int (2008) 1.11

Combining gene signatures improves prediction of breast cancer survival. PLoS One (2011) 1.11

PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain. Synapse (2004) 1.11

Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study. Prog Neuropsychopharmacol Biol Psychiatry (2006) 1.10

Mu- and delta-opioid receptor antagonists decrease proliferation and increase neurogenesis in cultures of rat adult hippocampal progenitors. Eur J Neurosci (2003) 1.08

Sex-dependent genetic markers of CYP3A4 expression and activity in human liver microsomes. Pharmacogenomics (2007) 1.07

Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis. Genome Biol (2014) 1.07

Serotonin transporter distribution and density in the cerebral cortex of alcoholic and nonalcoholic comparison subjects: a whole-hemisphere autoradiography study. Am J Psychiatry (2002) 1.05

Nuclear factor-κB1 controls the functional maturation of dendritic cells and prevents the activation of autoreactive T cells. Nat Med (2011) 1.03

Risk factors for suicide in schizophrenia: findings from a Swedish population-based case-control study. Schizophr Res (2009) 1.02

Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure. J Mol Cell Cardiol (2008) 1.02

Broadly impaired NK cell function in non-obese diabetic mice is partially restored by NK cell activation in vivo and by IL-12/IL-18 in vitro. Int Immunol (2004) 1.02

Update of carcinoembryonic antigen radioimmunotherapy with (131)I-labetuzumab after salvage resection of colorectal liver metastases: comparison of outcome to a contemporaneous control group. Ann Surg Oncol (2007) 1.02

The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: evidence from fixed- and random-effects meta-analyses. Am J Med Genet B Neuropsychiatr Genet (2006) 1.01

c-Rel but not NF-kappaB1 is important for T regulatory cell development. Eur J Immunol (2010) 1.01

A stochastic model for the assessment of the transmission pathways of heart and skeleton muscle inflammation, pancreas disease and infectious salmon anaemia in marine fish farms in Norway. Prev Vet Med (2009) 1.01

Dopamine D2 receptors and transporters in type 1 and 2 alcoholics measured with human whole hemisphere autoradiography. Hum Brain Mapp (2003) 1.00

Association between a disrupted-in-schizophrenia 1 (DISC1) single nucleotide polymorphism and schizophrenia in a combined Scandinavian case-control sample. Schizophr Res (2008) 1.00

Post-mortem human brain autoradiography of the norepinephrine transporter using (S,S)-[18F]FMeNER-D2. Eur Neuropsychopharmacol (2005) 0.99

Validation of oligoarrays for quantitative exploration of the transcriptome. BMC Genomics (2008) 0.99

Characterization of patients with schizophrenia and related psychoses: evaluation of different diagnostic procedures. Psychopathology (2006) 0.99

Effect of single and repeated methamphetamine treatment on neurotransmitter release in substantia nigra and neostriatum of the rat. J Neurochem (2002) 0.99

Quantitative study of synthetic Hox transcription factor-DNA interactions in live cells. Proc Natl Acad Sci U S A (2010) 0.99

Dopamine receptors and transporters in the brain reward circuits of type 1 and 2 alcoholics measured with human whole hemisphere autoradiography. Neuroimage (2003) 0.98

Attenuation of long-range temporal correlations in the amplitude dynamics of alpha and beta neuronal oscillations in patients with schizophrenia. Neuroimage (2012) 0.98

Haplotype analysis reveals tryptophan hydroxylase (TPH) 1 gene variants associated with major depression. Biol Psychiatry (2005) 0.97

Specific in vivo binding to the norepinephrine transporter demonstrated with the PET radioligand, (S,S)-[11C]MeNER. Nucl Med Biol (2003) 0.97

Identifying elemental genomic track types and representing them uniformly. BMC Bioinformatics (2011) 0.96

Big dynorphin, a prodynorphin-derived peptide produces NMDA receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice. Neuropsychopharmacology (2005) 0.96

Linear and non-linear dependencies between copy number aberrations and mRNA expression reveal distinct molecular pathways in breast cancer. BMC Bioinformatics (2011) 0.96

Suicide in schizophrenia. Expert Rev Neurother (2010) 0.96

Robust labeling and comparative preclinical characterization of DOTA-TOC and DOTA-TATE. Nucl Med Biol (2012) 0.95

The opioid peptides enkephalin and beta-endorphin in alcohol dependence. Biol Psychiatry (2008) 0.95

Haplotype analysis confirms association of the serotonin transporter (5-HTT) gene with schizophrenia but not with major depression. Am J Med Genet B Neuropsychiatr Genet (2008) 0.95

Regional expression of 5-HT1B receptor mRNA in the human brain. Synapse (2005) 0.95

Nociceptin/orphanin FQ modulates spatial learning via ORL-1 receptors in the dorsal hippocampus of the rat. Brain Res (2004) 0.94

YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription. Biochem Biophys Res Commun (2004) 0.94

Is the Gly82Ser polymorphism in the RAGE gene relevant to schizophrenia and the personality trait psychoticism? J Psychiatry Neurosci (2012) 0.94

Preparation of highly specific radioactivity [18F]flumazenil and its evaluation in cynomolgus monkey by positron emission tomography. Nucl Med Biol (2005) 0.94

D-amino acid oxidase activator gene (DAOA) variation affects cerebrospinal fluid homovanillic acid concentrations in healthy Caucasians. Eur Arch Psychiatry Clin Neurosci (2012) 0.93

Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas. Eur J Radiol (2010) 0.93

Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls. J Psychiatry Neurosci (2012) 0.93

Investigating relationships between cortical thickness and cognitive performance in patients with schizophrenia and healthy adults. Psychiatry Res (2010) 0.93

Monoamine related functional gene variants and relationships to monoamine metabolite concentrations in CSF of healthy volunteers. BMC Psychiatry (2004) 0.93

Prodynorphin storage and processing in axon terminals and dendrites. FASEB J (2006) 0.93

Prodynorphin transcripts and proteins differentially expressed and regulated in the adult human brain. FASEB J (2005) 0.92

Association analysis of ANK3 gene variants in nordic bipolar disorder and schizophrenia case-control samples. Am J Med Genet B Neuropsychiatr Genet (2011) 0.92

Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis. Psychiatr Genet (2003) 0.92

Estimated comparative integration hotspots identify different behaviors of retroviral gene transfer vectors. PLoS Comput Biol (2011) 0.92

The estrogen hypothesis of schizophrenia implicates glucose metabolism: association study in three independent samples. BMC Med Genet (2008) 0.91

Molecular disease map of bone characterizing the postmenopausal osteoporosis phenotype. J Bone Miner Res (2011) 0.91

Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism. Brain Res (2002) 0.91